RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene

Oncogene

Volumn 26, Issue 4, 2007, Pages 509-520

  Eguchi, T ^a   Takaki, T ^a   Itadani, H ^a   Kotani, H ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cytokinesis; DNA damage; ECT2; RB

Indexed keywords

ECT2 PROTEIN; PROTEIN; RETINOBLASTOMA PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL LINE; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTO ONCOGENE;

CELL DIVISION; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; E2F TRANSCRIPTION FACTORS; G2 PHASE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE;

EID: 33846547172     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209810     Document Type: Article

References (42)

1. Black EP, Huang E, Dressman H, Rempel R, Laakso N, Asa SL et al. (2003). Cancer Res 63: 3716-3723.
2. Blangy A, Lane HA, d'Herin P, Harper M, Kress M, Nigg EA. (1995). Cell 83: 1159-1169.
3. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. (1999). Proc Natl Acad Sci USA 96: 1002-1007.
4. Cam H, Dynlacht BD. (2003). Cancer Cell 3: 311-316.
5. Clemens F, Verma R, Ramnath J, Landolph JR. (2005). Toxicol Appl Pharmacol 206: 138-149.
6. Drechsel DN, Hyman AA, Hall A, Glotzer M. (1997). Curr Biol 7: 12-23.
7. Dyson N. (1998). Genes Dev 12: 2245-2262.
8. Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA. (2000). Mol Cell Biol 20: 4210-4223.
9. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM et al. (1986). Nature 323: 643-646.
10. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF. (1987). Science 236: 1657-1661.
11. Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DF, Honda R et al. (2004). J Cell Biol 166: 179-191.
12. Hateboer G, Wobst A, Petersen BO, Le Cam L, Vigo E, Sardet C et al. (1998). Mol Cell Biol 18: 6679-6697.
13. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M et al. (2004). Nature 430: 797-802.
14. Hill E, Clarke M, Barr FA. (2000). EMBO J 19: 5711-5719.
15. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M et al. (2001). Mol Cell Biol 21: 4684-4699.
16. Jiang Y, Saavedra HI, Holloway MP, Leone G, Altura RA. (2004). J Biol Chem 279: 40511-40520.
17. Johnson DG, Schwarz JK, Cress WD, Nevins JR. (1993). Nature 365: 349-352.
18. Kimura K, Cuvier O, Hirano T. (2001). J Biol Chem 276: 5417-5420.
19. Kimura K, Tsuji T, Takada Y, Miki T, Narumiya S. (2000). J Biol Chem 275: 17233-17236.
20. Mayhew CN, Bosco EE, Fox SR, Okaya T, Tarapore P, Schwemberger SJ et al. (2005). Cancer Res 65: 4568-4577.
21. Miki T, Smith CL, Long JE, Eva A, Fleming TP. (1993). Nature 362: 462-465.
22. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E et al. (2001). Genes Dev 15: 267-285.
23. Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL et al. (2004). Mol Cancer Res 2: 453-463.
24. Polager S, Ginsberg D. (2003). J Biol Chem 278: 1443-1449.
25. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. (2002). Genes Dev 16: 245-256.
26. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. (2003). Nature 424: 223-228.
27. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B et al. (2000). Genes Dev 14: 3037-3050.
28. Sahai E, Marshall CJ. (2002). Nat Rev Cancer 2: 133-142.
29. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I et al. (2004). J Biol Chem 279: 7169-7179.
30. Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H et al. (2003). J Cell Biochem 90: 819-836.
31. Sakata H, Rubin JS, Taylor WG, Miki T. (2000). Hepatology 32: 193-199.
32. Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Durr P. (1994). Oncogene 9: 3475-3482.
33. Sherr CJ. (2000). Cancer Res 60: 3689-3695.
34. Sherr CJ, McCormick F. (2002). Cancer Cell 2: 103-112.
35. Sherr CJ, Roberts JM. (1999). Genes Dev 13: 1501-1512.
36. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T. (1999). J Cell Biol 147: 921-928.
37. Wang JY, Naderi S, Chen TT. (2001). Acta Oncol 40: 689-695.
38. Weinberg RA. (1995). Cell 81: 323-330.
39. Westwick JK, Lee RJ, Lambert QT, Symons M, Pestell RG, Der CJ et al. (1998). J Biol Chem 273: 16739-16747.
40. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR et al. (1998). Proc Natl Acad Sci USA 95: 3603-3608.
41. Yen CC, Chen YJ, Pan CC, Lu KH, Chen PC, Hsia JY et al. (2005). World J Gastroenterol 11: 1267-1272.
42. Young AP, Nagarajan R, Longmore GD. (2003). Oncogene 22: 7209-7217.